tradingkey.logo

ICON PLC

ICLR
174.530USD
+9.980+6.07%
Close 11/25, 16:00ETQuotes delayed by 15 min
13.33BMarket Cap
22.23P/E TTM

ICON PLC

174.530
+9.980+6.07%

More Details of ICON PLC Company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

ICON PLC Info

Ticker SymbolICLR
Company nameICON PLC
IPO dateMay 15, 1998
CEODr. Stephen (Steve) Cutler, Ph.D.
Number of employees41900
Security typeOrdinary Share
Fiscal year-endMay 15
AddressSouth County Business Park
CityDUBLIN
Stock exchangeNASDAQ Global Select Consolidated
CountryIreland
Postal code- -
Phone35312912000
Websitehttps://www.iconplc.com/
Ticker SymbolICLR
IPO dateMay 15, 1998
CEODr. Stephen (Steve) Cutler, Ph.D.

Company Executives of ICON PLC

Name
Name/Position
Position
Shareholding
Change
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Executive Officer, Chief Operating Officer
Chief Executive Officer, Chief Operating Officer
--
--
Ms. Anne C. Whitaker
Ms. Anne C. Whitaker
Independent Director
Independent Director
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Ireland
884.26M
43.83%
United States
572.31M
28.37%
Rest of Europe
357.19M
17.71%
Rest of the World
203.60M
10.09%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Artisan Partners Limited Partnership
9.26%
Wellington Management Company, LLP
6.07%
Orbis Investment Management Ltd.
5.42%
Principal Global Investors (Equity)
4.29%
MFS Investment Management
4.17%
Other
70.78%
Shareholders
Shareholders
Proportion
Artisan Partners Limited Partnership
9.26%
Wellington Management Company, LLP
6.07%
Orbis Investment Management Ltd.
5.42%
Principal Global Investors (Equity)
4.29%
MFS Investment Management
4.17%
Other
70.78%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
48.38%
Investment Advisor
39.19%
Hedge Fund
8.50%
Pension Fund
2.37%
Research Firm
2.03%
Sovereign Wealth Fund
1.43%
Family Office
1.09%
Family Office
1.09%
Bank and Trust
1.05%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1350
79.42M
104.00%
-10.34M
2025Q2
1335
74.28M
95.51%
-11.33M
2025Q1
1362
81.04M
101.97%
-5.18M
2024Q4
1334
80.88M
97.97%
-5.29M
2024Q3
1290
83.28M
100.86%
-2.02M
2024Q2
1273
83.12M
100.37%
-2.47M
2024Q1
1254
83.08M
100.49%
-3.81M
2023Q4
1237
84.94M
102.98%
-3.00M
2023Q3
1213
86.31M
104.85%
-1.65M
2023Q2
1199
85.95M
104.64%
+2.46M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Artisan Partners Limited Partnership
7.18M
9.24%
+2.89M
+67.44%
Jun 30, 2025
Wellington Management Company, LLP
3.66M
4.71%
-31.29K
-0.85%
Jun 30, 2025
MFS Investment Management
3.42M
4.4%
+598.95K
+21.19%
Jun 30, 2025
Ninety One UK Limited
2.99M
3.85%
+75.47K
+2.59%
Jun 30, 2025
Invesco Advisers, Inc.
2.53M
3.25%
+49.54K
+2.00%
Jun 30, 2025
Harris Associates L.P.
1.64M
2.11%
+1.63M
+12752.56%
Jun 30, 2025
Templeton Investment Counsel, L.L.C.
1.69M
2.17%
-127.09K
-7.01%
Jun 30, 2025
Ruane, Cunniff & Goldfarb L.P.
1.71M
2.2%
+453.83K
+36.18%
Jun 30, 2025
View more

Related ETFs

Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
iShares MSCI Ireland ETF
4.59%
VanEck Biotech ETF
3.38%
Harbor Health Care ETF
3.14%
Polen Capital International Growth ETF
3.14%
Motley Fool Global Opportunities ETF
2.9%
Invesco Bloomberg Pricing Power ETF
1.93%
Running Oak Efficient Growth ETF
1.83%
FPA Global Equity ETF
1.8%
Brandes US Value ETF
1.78%
Tema Durable Quality ETF
1.73%
View more
iShares MSCI Ireland ETF
Proportion4.59%
VanEck Biotech ETF
Proportion3.38%
Harbor Health Care ETF
Proportion3.14%
Polen Capital International Growth ETF
Proportion3.14%
Motley Fool Global Opportunities ETF
Proportion2.9%
Invesco Bloomberg Pricing Power ETF
Proportion1.93%
Running Oak Efficient Growth ETF
Proportion1.83%
FPA Global Equity ETF
Proportion1.8%
Brandes US Value ETF
Proportion1.78%
Tema Durable Quality ETF
Proportion1.73%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of ICON PLC?

The top five shareholders of ICON PLC are:
Artisan Partners Limited Partnership holds 7.18M shares, accounting for 9.24% of the total shares.
Wellington Management Company, LLP holds 3.66M shares, accounting for 4.71% of the total shares.
MFS Investment Management holds 3.42M shares, accounting for 4.40% of the total shares.
Ninety One UK Limited holds 2.99M shares, accounting for 3.85% of the total shares.
Invesco Advisers, Inc. holds 2.53M shares, accounting for 3.25% of the total shares.

What are the top three shareholder types of ICON PLC?

The top three shareholder types of ICON PLC are:
Artisan Partners Limited Partnership
Wellington Management Company, LLP
Orbis Investment Management Ltd.

How many institutions hold shares of ICON PLC (ICLR)?

As of 2025Q3, 1350 institutions hold shares of ICON PLC, with a combined market value of approximately 79.42M, accounting for 104.00% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 8.49%.

What is the biggest source of revenue for ICON PLC?

In FY2025Q2, the -- business generated the highest revenue for ICON PLC, amounting to -- and accounting for --% of total revenue.
KeyAI